Black Rock Inc. Acadia Pharmaceuticals Inc Transaction History

Black Rock Inc.

$4.23 Trillion
Q1 2024

A detailed history of Black Rock Inc. transactions in Acadia Pharmaceuticals Inc stock. As of the latest transaction made, Black Rock Inc. holds 11,668,740 shares of ACAD stock, worth $182 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

11,668,740

Previous 11,410,483 2.26%

Holding current value

$182 Million

Previous $357 Million 39.61%

% of portfolio

0.01%

Previous 0.01%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$17.79 - $30.86 $4.59 Million - $7.97 Million	258,257 Added 2.26%	11,668,740 $216 Million
Q4 2023 Feb 13, 2024	BUY	$20.78 - $31.77 $28.7 Million - $43.9 Million	1,381,898 Added 13.78%	11,410,483 $357 Million
Q3 2023 Nov 13, 2023	SELL	$20.84 - $33.47 $227,489 - $365,358	-10,916 Reduced 0.11%	10,028,585 $209 Million
Q2 2023 Aug 11, 2023	BUY	$17.8 - $25.65 $3.03 Million - $4.37 Million	170,370 Added 1.73%	10,039,501 $240 Million
Q1 2023 May 12, 2023	SELL	$16.32 - $20.92 $6.37 Million - $8.16 Million	-390,053 Reduced 3.8%	9,869,131 $186 Million

Q4 2022 Feb 13, 2023	BUY	$14.2 - $18.63 $4.06 Million - $5.33 Million	286,029 Added 2.87%	10,259,184 $163 Million
Q3 2022 Nov 14, 2022	BUY	$14.11 - $18.27 $3.27 Million - $4.24 Million	231,841 Added 2.38%	9,973,155 $163 Million
Q2 2022 Aug 12, 2022	SELL	$13.01 - $27.22 $2.98 Million - $6.23 Million	-228,709 Reduced 2.29%	9,741,314 $137 Million
Q1 2022 May 12, 2022	SELL	$20.94 - $27.5 $1.89 Million - $2.48 Million	-90,289 Reduced 0.9%	9,970,023 $241 Million
Q4 2021 Feb 10, 2022	SELL	$16.79 - $27.09 $1.59 Million - $2.56 Million	-94,639 Reduced 0.93%	10,060,312 $235 Million
Q3 2021 Nov 09, 2021	BUY	$15.78 - $24.77 $248,503 - $390,077	15,748 Added 0.16%	10,154,951 $169 Million
Q2 2021 Aug 11, 2021	BUY	$19.4 - $27.42 $197 Million - $278 Million	10,139,203 New	10,139,203 $247 Million

Others Institutions Holding ACAD

# of Institutions

299

Shares Held

158M

Call Options Held

1.88M

Put Options Held

688K

View Full List

About ACADIA PHARMACEUTICALS INC

Ticker ACAD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 161,843,008
Market Cap $2.52B
Description
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...

More about ACAD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.

Account